Skip to main content

Table 2 Factors associated with patients’ financial accessibility to the essential drug list among rural and urban groups attending PHC units, Giza Governorate, Egypt, 2019

From: Perspectives of pharmaceutical stakeholders on determinants of medicines accessibility at the primary care level

Financial accessibility

Residence

P value*

Rural unit (N = 138) (%)

Urban unit (N = 138) (%)

Willingness to pay for the medicine

 Yes

100 (72.4)

112 (81.1)

0.133

 No

38 (27.6)

26 (18.9)

Ability to pay for the medicine

 Yes

98 (71.1)

87 (63.1)

0.303

 No

40 (28.9)

51 (36.9)

Coping mechanisms

Borrowing to buy the medicine

  Yes

21 (15.3)

21 (15.3)

1

  No

117 (84.7)

117 (84.7)

Selling assets to buy the medicine

  Yes

7 (5.1)

4 (2.9)

0.721

  No

131 (94.9)

134 (97.1)

Out of pocket expenses (Egyptian pounds L.E.)

 

Median (IQR)

Median (IQR)

P value**

Expenses on medicine in the current visit

15.75 (5‑73)

23.5 (2‑103)

˂ 0.001

Expenses on medicine/month

200 (20‑500)

100 (8‑550)

0.056

The estimated income per family member

222.2 (75‑1000)

333.3 (83.3‑2250)

˂ 0.001

  1. *P value was calculated using chi-square test
  2. **P value was calculated using the Mann-Whitney test
  3. P value is statistically significant < 0.05